PRLR and breast cancer: Moreover, genomic analysis of mammary tumors arising in the 129:Stat1−/− mouse established they almost always harbored a truncating exon 10 mutation of the prolactin receptor (PRLR) that was tumorigenic when heterozygously expressed in embryonic fibroblasts lacking Stat1 but overexpressing Jak2 [17].